Clarivate (NYSE:CLVT - Get Free Report) is set to release its earnings data before the market opens on Wednesday, November 6th. Analysts expect Clarivate to post earnings of $0.16 per share for the quarter. Clarivate has set its FY24 guidance at $0.70 to $0.80 EPS and its FY 2024 guidance at 0.700-0.800 EPS.Parties that wish to listen to the company's conference call can do so using this link.
Clarivate (NYSE:CLVT - Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.02. The business had revenue of $650.30 million for the quarter, compared to analyst estimates of $651.94 million. Clarivate had a positive return on equity of 10.01% and a negative net margin of 46.53%. The company's quarterly revenue was down 2.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.16 EPS. On average, analysts expect Clarivate to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Clarivate Price Performance
NYSE CLVT remained flat at $6.53 during trading on Wednesday. The company's stock had a trading volume of 1,989,917 shares, compared to its average volume of 4,122,304. The company has a market capitalization of $4.73 billion, a PE ratio of -3.42 and a beta of 1.17. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.90 and a quick ratio of 0.90. The stock has a 50 day moving average of $6.68 and a two-hundred day moving average of $6.33. Clarivate has a fifty-two week low of $4.97 and a fifty-two week high of $9.60.
Wall Street Analyst Weigh In
CLVT has been the topic of a number of research analyst reports. Barclays decreased their target price on Clarivate from $6.00 to $5.00 and set an "underweight" rating on the stock in a research note on Wednesday, August 7th. Royal Bank of Canada reduced their price objective on Clarivate from $8.00 to $7.00 and set a "sector perform" rating on the stock in a research report on Wednesday, August 7th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Clarivate has an average rating of "Hold" and an average target price of $7.58.
View Our Latest Report on Clarivate
Insiders Place Their Bets
In other Clarivate news, insider Bar Veinstein sold 120,000 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $7.00, for a total value of $840,000.00. Following the completion of the sale, the insider now owns 976,583 shares in the company, valued at approximately $6,836,081. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Clarivate news, insider Bar Veinstein sold 120,000 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $7.00, for a total value of $840,000.00. Following the completion of the sale, the insider now owns 976,583 shares in the company, valued at approximately $6,836,081. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Saurabh Saha sold 17,646 shares of the firm's stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $6.75, for a total value of $119,110.50. Following the completion of the transaction, the director now owns 23,741 shares of the company's stock, valued at approximately $160,251.75. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 197,646 shares of company stock worth $1,379,111. 23.14% of the stock is currently owned by company insiders.
About Clarivate
(
Get Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Recommended Stories
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
